Rotavirus gastroenteritis in children less than five years of age in primary care settings in Bulgaria: an observational study

Abstract

Background: Rotavirus (RV) causes a high proportion of acute gastroenteritis (AGE) cases, especially among children under the age of five years old. This surveillance study was undertaken to study the incidence and severity of rotavirus gastroenteritis (RVGE) in primary care settings in Bulgaria over a one-year period.

Methods: In this prospective, observational study of AGE cases in children under five years of age presenting in the primary care setting over a one year period, stool samples were collected and tested for RV using a rapid visual immunochromatographic test kit. After the first visit, parents monitored their child for about two weeks and reported the symptoms experienced by the child during the follow-up period to the physician in a follow-up phone call. The percentage of RVGE cases among AGE was calculated and the severity of AGE (according to the 20-point Vesikari scale) was assessed by the physician based on the symptoms reported by the parents. The seasonality of RVGE was also studied.

Results: The proportion of RVGE among the 624 AGE cases examined was 25.5%. Severe AGE was experienced by 81.8% RV-positive and 54.6% RV-negative children (p-value <0.001) and a third of all severe AGE cases occurred in RV-positive patients. A multivariate logistic regression analysis of the determinants of hospitalization indicated that severity of disease and RV-positivity were the statistically significant variables explaining hospitalization of AGE cases; even controlling for severity, RV-positive patients were more often hospitalized than RV-negative ones. RVGE cases occurred throughout the year, with peaks during August and September.

Conclusion: Our study emphasizes that RV is an important cause of AGE in children under five presenting in primary care settings in Bulgaria and a disproportionately high proportion of severe AGE cases may be attributed to RV infections.

Trial registration number: NCT01733849.

Keywords: RV disease burden; Rotavirus; acute gastroenteritis; primary care settings.

Conflict of interest statement

Prof. Tiholova received grants from the GSK group of companies, and personal fees from GSK group of companies, Sanofi-Pasteur, MSD, and Biocodex, outside the submitted work. Kusuma Gopala, Magda Berberova, Margarita Strokova-Stoilova and Monica Tafalla are employed by the GSK group of companies. Monica Tafalla holds stock options and restricted shares from the GSK group of companies.

Figures

Figure 1.. Number of RVGE and AGE cases and RVGE as a proportion of all AGE cases, by age group (months, mo)

Figure 2.. Monthly incidence of AGE and RVGE cases